Trial Profile
A Phase I, open-label, 2-period, single-sequence, drug interaction study to assess steady-state plasma methadone enantiomer pharmacokinetics following co-administration of methadone QD with fosamprenavir 700mg BID + RTV [ritonavir] 100mg BID in opiate-dependent, HIV seronegative, adult subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Fosamprenavir (Primary) ; Methadone; Ritonavir
- Indications Opioid-related disorders
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 31 Jul 2007 New trial record.